PATENT CLAIM ANALYSIS

Application Number: 16104226
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "450000"]

Abstract:
Fusion proteins comprising a carrier protein and a Human Rhinovirus (HRV) peptide, and immunogenic compositions containing such fusion proteins.

Claim (Index 15):
The method of  claim 10 , wherein said adjuvant comprises 3D-MPL and QS21 in a liposome formulation.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 96.0
- Lexical Diversity: 1.15
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14774729', '12442988', '14182731', '11795623', '13504766']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8045294381873603
- 35 USC 102 Novelty (BERT): 0.6025338655572816
- Combined Prediction Score: 0.7843298809243525
- Mean Citation Score: 470.38241
- Max Citation Score: 770.5715
- Similarity Product: 443.99678275793786

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test